MedPath

Schweiger Dermatology, PLLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Restylane Silk Acne Scar Efficacy Evaluation Study

Not Applicable
Terminated
Conditions
Acne
Acne Scars
AdverseEvent
Interventions
Device: Saline, 1.0 ml
Device: Restylane Silk, 1.0 ml
First Posted Date
2016-11-04
Last Posted Date
2019-05-10
Lead Sponsor
Schweiger Dermatology, PLLC
Target Recruit Count
26
Registration Number
NCT02955381
Locations
🇺🇸

Schweiger Dermatology, PLLC, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath